1377 Evaluation Webform



Emerging Options for Elevated LDL Cholesterol:
Focus on PCSK9 Inhibitors

We greatly value your opinion. Your responses in this evaluation will be used in future planning of new courses and offerings for members of the healthcare team.

Click on the “Submit” button when you have finished the evaluation and the “Next” button to obtain your certificate

Strongly Agree Agree Neutral Disagree Strongly Disagree
Discuss the sequelae of elevated low-density lipoprotein cholesterol (LDL-C)
Describe the mechanism of action of proprotein convertase sutilisin/kexin type 9 (PCSK9) inhibitors
Discuss the efficacy and safety of PCSK9 inhibitors
Characterize how PCSK9 inhibitors may best be used in the management of LDL-C
Provide appropriate care and counsel for patients and their families.
Strongly Agree Agree Neutral Disagree Strongly Disagree
The faculty were effective in presenting the material
The content was evidence based
The educational material provided useful information for my practice
The activity enhanced my current knowledge base
The activity provided appropriate and effective opportunities for active learning (e.g., case studies, discussion, Q&A, etc.)
The opportunities provided to assess my own learning were appropriate (e.g., questions before, during or after the activity)
Please use a number (example 250):
Very confident Somewhat confident Unsure Not very confident